AZITRA INC (AZTR)
AMEXHealth CareBiotechnologySnapshot 2026-09-04
$0.18-0.28%
Close 2026-09-04 · 1-day change
AMEXHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · AZTR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenues | — | — | 0.0 | 0.7 | 0.3 | — |
| Total Revenues | — | — | 0.0 | 0.7 | 0.3 | — |
| Operating Expenses & Income | ||||||
| R&D Expenses | 5.1 | 4.8 | 4.7 | 3.6 | 6.1 | — |
| Operating Income | (12.3) | (11.0) | (11.0) | (7.5) | (9.5) | — |
| Earnings from Continuing Operations | ||||||
| Interest Expense | — | 0.0 | 0.0 | 0.2 | 0.3 | — |
| Other Non-Operating Income / Expenses | 0.1 | 0.0 | 2.0 | (3.8) | (1.2) | — |
| EBT, Incl. Unusual Items | (12.3) | (10.9) | (9.0) | (11.3) | (10.7) | — |
| Income Tax Expense | — | 0.0 | 0.0 | 0.0 | — | — |
| Net Income | ||||||
| Net Income | (12.3) | (11.0) | (9.0) | (11.3) | (10.7) | — |
| Per Share | ||||||
| Basic EPS | (0.64) | (2.25) | (2.37) | (54.98) | (12.74) | — |
| Diluted EPS | (0.64) | (2.25) | (2.37) | (54.98) | (12.74) | — |
| Basic Weighted Avg Shares | 19.3 | 4.9 | 3.8 | 0.2 | 1.1 | — |
| Diluted Weighted Avg Shares | 19.3 | 4.9 | 3.8 | 0.2 | 1.1 | — |
| Supplemental | ||||||
| EBITDA | — | (10.8) | (10.9) | (7.3) | (9.3) | — |
| EBIT | (12.3) | (11.0) | (11.0) | (7.5) | (9.5) | — |
| Effective Tax Rate | — | — | — | -0.2% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.